Streetbeat News

Stock Prices

AGL

AIMD

APLT

ELEV

MESO

During Friday's intraday session, several healthcare stocks experienced significant movements. Ainos (AIMD) led the gainers with a 74.0% increase, while Mesoblast (MESO) saw the largest decline among the losers, dropping 50.0%. Other notable gainers include Elevation Oncology (ELEV), Alaunos Therapeutics (TCRT), Axogen (AXGN), NexImmune (NEXI), and Inovio Pharmaceuticals (INO). On the losing side, Applied Therapeutics (APLT), Avenue Therapeutics (ATXI), Inspire Veterinary (IVP), Agilon Health (AGL), and Omega Therapeutics (OMGA) also saw significant drops in their stock prices.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 5:31 pm

KSCP

NXU

SWVL

TURB

VIEW

YGMZ

During Friday's intraday session, several industrial stocks experienced significant movements. Swvl Holdings (SWVL) led the gainers with a 35.4% rise, while View (VIEW) saw the largest decline among the losers, dropping 20.2%. Other notable gainers included Nxu (NXU), Knightscope (KSCP), Wheels Up Experience (UP), MingZhu Logistics Holdings (YGMZ), and Turbo Energy (TURB). On the losing side, stocks such as Applied UV (AUVIP), Shengfeng Development (SFWL), Nuburu (BURU), FREYR Battery (FREY), and Gaucho Group Holdings (VINO) also saw significant declines.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 5:31 pm

ATGL

CISO

DUOT

MOBX

VERB

During Friday's intraday session, several information technology stocks experienced significant movements. Alpha Technology Group's stock rose by 29.1%, while Aurora Mobile and Duos Technologies Group also saw substantial gains of 22.64% and 20.98%, respectively. Conversely, Mobix Labs, Verb Tech, and CISO Global were among the biggest losers, with their stocks falling by 14.4%, 13.91%, and 13.88%. Other notable movements included gains for Cemtrex, Unisys, and Transact Technologies, and losses for Argo Blockchain, MicroCloud Hologram, and MariaDB.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 5:30 pm

Brookfield (NYSE:BN) has delivered an average annual return of 12.83% over the past 20 years, outperforming the market by 5.44%. A $100 investment in BN 20 years ago would be worth $1,135.46 today. The company's current market capitalization stands at $59.72 billion.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 5:30 pm

FCX

Over the past 5 years, Freeport-McMoRan (NYSE:FCX) has produced an average annual return of 29.92%, outperforming the market by 17.17% on an annualized basis. A $100 investment in FCX stock 5 years ago would be worth $376.82 today. The company's current market capitalization stands at $59.25 billion.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 5:30 pm

PYPD

PolyPid's stock is trading higher following the announcement of a $16.2 million private placement, which involves issuing 3,371,312 shares at a price of $4.81 each.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 5:30 pm

FHN

Raymond James analyst Michael Rose has upgraded First Horizon (NYSE:FHN) from Outperform to Strong Buy and increased the price target from $13 to $17.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 5:29 pm

COST

Costco Wholesale Corp (NASDAQ:COST) reported a 9.9% year-on-year increase in December sales to $26.15 billion, with shares up 47% over the past year. The adjusted headline comp of 5.5% exceeded Telsey Advisory Group's target of 2.0%. Analyst Joseph Feldman maintains an Outperform rating on Costco with a $700 price target, citing strong performance, market share leadership, and solid traffic as consumers seek value. Despite potential short-term challenges, Costco is expected to sustain growth with a forecasted slight decline in January sales due to gas and foreign exchange effects.

Portfolio Pulse from Surbhi Jain

January 05, 2024 | 5:27 pm

IVP

Inspire Veterinary Partners' stock is trading lower following the filing of a prospectus for a public offering of up to $5 million.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 5:27 pm

STLA

Stellantis NV (NYSE:STLA) faced production issues with its electric 500e model in Italy due to delayed government EV incentives, leading to fewer units produced than planned. Despite this, Stellantis' overall vehicle production in Italy increased by 9.6% last year. The Italian government's new plans to support EV purchases with €930 million may boost future sales. STLA shares saw a slight increase of 0.92% to $22.42.

Portfolio Pulse from Shivani Kumaresan

January 05, 2024 | 5:23 pm